Sign up to save your podcasts
Or
Share Stem Cell Therapies, AI Legislation, and Chip Manufacturing Shifts
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Stem Cell Therapies, AI Legislation, and Chip Manufacturing Shifts
In this episode, we explore Gallant's pioneering stem cell therapies for pets, delve into TSMC's strategic shifts amid U.S. tariffs, and discuss Microsoft's operational changes in Pakistan. We also cover the EU's steadfast AI legislation plans, an Xbox exec's AI advice for laid-off workers, and investment insights into OpenAI and Anthropic. Finally, we highlight cap table management strategies from TechCrunch All Stage 2025.
View all episodes
By The Pulse PressIn this episode, we explore Gallant's pioneering stem cell therapies for pets, delve into TSMC's strategic shifts amid U.S. tariffs, and discuss Microsoft's operational changes in Pakistan. We also cover the EU's steadfast AI legislation plans, an Xbox exec's AI advice for laid-off workers, and investment insights into OpenAI and Anthropic. Finally, we highlight cap table management strategies from TechCrunch All Stage 2025.